𝔖 Bobbio Scriptorium
✦   LIBER   ✦

KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression

✍ Scribed by Oliveira, C; Velho, S; Moutinho, C; Ferreira, A; Preto, A; Domingo, E; Capelinha, A F; Duval, A; Hamelin, R; Machado, J C

Book ID
110070771
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
208 KB
Volume
26
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Frequency of KRAS, BRAF, and NRAS mutati
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
✍ Cecily P. Vaughn; Scott D. ZoBell; Larissa V. Furtado; Christine L. Baker; Wade πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract Mutational analysis of __KRAS__ codons 12 and 13 is standard for patients with metastatic colorectal cancer since mutations in these codons predict lack of response to anti‐EGFR therapies. However, even among patients whose tumors are wildtype for __KRAS__ codons 12 and 13, only a subse

Mutations of the BRAF gene in ulcerative
Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma
✍ Daniela E. Aust; Michael Haase; Lyudmyla Dobryden; Annett Markwarth; Udo LΓΆhrs; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 263 KB πŸ‘ 1 views

## Abstract The __Raf/MEK/ERK (MAPK)__ signal transduction cascade is an important mediator of a number of cellular fates including growth, proliferation and survival. The __BRAF__ gene is activated by oncogenic __Ras__, leading to cooperative effects in cells responding to growth factor signals. O